基于MSP/RON通路探讨桂皮醛抑制破骨细胞活化干预类风湿性关节骨破坏的作用机制研究
批准号:
82104497
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
成文翔
依托单位:
学科分类:
中药抗炎与免疫药理
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
成文翔
中文摘要
关节骨破坏是类风湿性关节炎(RA)的主要病理特征,其危害极大。RA归属于中医痹症,温经通脉治疗可显著改善RA患者的症状。我们的前期结果提示,桂枝的主要成分桂皮醛具有抗炎作用并可显著改善RA关节软骨的破坏;生物信息学预测确定桂皮醛与促进破骨细胞活化的巨噬细胞刺激蛋白MSP高度相关,酪氨酸激酶受体RON特异性表达在成熟破骨细胞表面,MSP是RON目前已知的唯一配体;经实验发现桂皮醛可抑制体外MSP诱导的骨吸收。因此,我们推测桂皮醛可靶向调控MSP/RON信号通路抑制破骨细胞活化。本项目拟在动物模型中以影像学、骨组织计量学等手段系统评价桂皮醛对炎性环境下关节软骨及骨组织的保护作用,结合体外骨陷窝实验等证实其抑制破骨细胞活化的作用,借助免疫共沉淀、免疫荧光及表面等离子体共振等技术系统阐明桂皮醛对MSP/RON的调控机制。为探索RA关节骨破坏防治的新途径和发展新型的RON靶向抑制剂提供实验依据。
英文摘要
Rheumatoid arthritis (RA) is a complex multi-system inflammatory disorder characterized by progressive joint destruction. Recent studies have revealed that osteoclasts are involved in the pathogenesis of bone destruction in RA and considered as a potential therapeutic target of the disease. Recently, it was demonstrated the role of macrophage-stimulating protein (MSP) and its receptor, RON tyrosine kinase in the signal pathway of osteoclast activation. Ramulus Cinnamomi, a traditional Chinese herb is widely recognized for their various applications in the medicine based on its antioxidant, antipyretic, anti-inflammatory, and antineoplastic activities. Cinnamaldehyde has been extensively investigated and considered to be the characteristic active constituents of Cinnamomi cassia. Guided by the results of bioinformatics predictions, we proposed the therapeutic potential of targeting MSP in RA using cinnamaldehyde. Our preliminary results provide compelling evidence that cinnamaldehyde could significantly reduce the damage of articular cartilage in Collagen induced arthritis (CIA) animal model. We have also observed that blockade of MSP-induced osteoclast activity reduces bone resorption in vitro. These data lead to our hypothesis that cinnamaldehyde can inhibit osteoclast activation by regulating MSP/RON signaling pathway. .In this study, we plan to systematically assess the effect of cinnamaldehyde on preventing articular cartilage and bone damage in inflammatory environment by MRI, micro-CT and bone histomorphometry in CIA animal models. We investigate the regulation of MSP/RON signaling pathway by cinnamaldehyde using western blot and immunofluorescence. In addition, we will explore the mechanisms of action of cinnamaldehyde–protein interactions by surface plasmon resonance and immunoprecipitation. Our study will provide a potential selectively inhibitor of Ron target for therapeutic of RA bone resorption.
类风湿性关节炎(Rheumatoid arthritis,RA)是一种系统性自身免疫性疾病,主要病理特点是滑膜慢性炎症,伴随血管翳的增生,最终造成对软骨及骨关节的侵袭破坏。破骨细胞是体内唯一具有骨吸收活性的多核巨细胞。RA发病的过程中,由于免疫炎症的启动,破骨细胞被激活,其数量和活力的增加打破了成骨/破骨的稳态,引起骨吸收增强,导致RA患者骨代谢失衡,最终引起软骨以及骨破坏。项目面向RA骨破坏防治的迫切需求,结合我国中医药特色,在前期实验数据基础上,应用现代生物技术手段,对桂皮醛的药物作用及分子机制进行系统性的研究。本研究明确了桂皮醛可缓解小鼠CIA模型的疾病进展,并且具有关节骨保护作用效果;进一步通过转录组学、免疫组织化学分析等技术手段,阐明了桂皮醛对破骨细胞中MSP/RON信号通路的作用;同时,项目组发现了桂皮醛对代谢调控有一定的作用,筛选并验证了新的RA骨破坏相关的靶点ANGPTL4,并初步探索了其抑制破骨活化的作用机制,进一步发现桂皮醛可通过干预细胞代谢发挥其药理作用。本研究围绕RA骨破坏的疾病机制开展了系统性研究工作,筛选并鉴定出RA骨破坏治疗的新靶点,为靶向治疗RA骨破坏的提供了科学数据。.项目执行期间,共发表SCI论文3篇。其中,项目负责人作为共同通讯作者,发表SCI论文3篇,其中2篇为JCR分区Q1区文章,其中1篇发表在Cell Press出版社旗下Molecular Therapy杂志上(IF:12.1,Q1)。项目负责人作为第三发明人,申请国家发明专利1项。项目执行期间参加中医药风湿疾病领域内学术会议3次,口头汇报2次。
国内基金
海外基金